Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Salivation in Parkinson's Disease”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Study completedNCT00515437
What this trial is testing

A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients

Who this might be right for
Drooling
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 54
Testing effectiveness (Phase 2)Study completedNCT01370811
What this trial is testing

A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease

Who this might be right for
Sialorrhoea
Orient Pharma Co., Ltd. 24
Not applicableStudy completedNCT06090929
What this trial is testing

STN-DBS and the Risk of Sialorrhea

Who this might be right for
Parkinson Disease
Qilu Hospital of Shandong University 234
Post-approval studies (Phase 4)Study completedNCT06319118
What this trial is testing

A Clinical Study of Dihydroergotine Mesylate Extended-release Tablets for the Treatment of Drooling in Parkinson's Disease.

Who this might be right for
Salivation in Parkinson's Disease
Second Affiliated Hospital of Soochow University 120
Testing effectiveness (Phase 2)Study completedNCT01844648
What this trial is testing

Study of the Safety and Efficacy of Tropicamide Thin Films to Reduce Hypersalivation in Parkinson's Patients

Who this might be right for
Sialorrhea (Excessive Drooling)
NeuroHealing Pharmaceuticals Inc. 30
Testing effectiveness (Phase 2)WithdrawnNCT01565395
What this trial is testing

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Parkinson DiseaseAmyotrophic Lateral Sclerosis
Beth Israel Deaconess Medical Center
Testing effectiveness (Phase 2)UnknownNCT02382198
What this trial is testing

Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease

Who this might be right for
SialorrheaParkinson's Disease
Ottawa Hospital Research Institute 28
Testing effectiveness (Phase 2)Study completedNCT01653132
What this trial is testing

Incobotulinum Toxin A (Xeomin®) for Troublesome Sialorrhea in Parkinson's Disease (PD)/Parkinsonism

Who this might be right for
Sialorrhea
Beth Israel Deaconess Medical Center 10
Not applicableUnknownNCT06035913
What this trial is testing

Mid-and Long-term Efficacy of Ergot Alkaloids in the Treatment of Salivation in Patients With Parkinson's Disease.

Who this might be right for
Main Heading (Descriptor) Terms
Nanjing First Hospital, Nanjing Medical University 80
Large-scale testing (Phase 3)Study completedNCT02091739
What this trial is testing

Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological Conditions

Who this might be right for
Chronic Troublesome SialorrheaParkinson's DiseasePost-stroke+1 more
Merz Pharmaceuticals GmbH 184
Not applicableLooking for participantsNCT07588191
What this trial is testing

Effects of Transcutaneous Vagus Nerve Stimulation in Parkinson´s Disease

Who this might be right for
Transcutaneous Vagal Nerve Stimulation (tVNS)Parkinson Disease (PD)
Universidade da Coruña 46
Large-scale testing (Phase 3)Study completedNCT01994109
What this trial is testing

Efficacy and Safety Study of MYOBLOC® in the Treatment of Sialorrhea in Adult Subjects

Who this might be right for
Sialorrhea
Solstice Neurosciences, LLC, a subsidiary of US WorldMeds, LLC 187
Testing effectiveness (Phase 2)Study completedNCT00761137
What this trial is testing

Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients

Who this might be right for
Sialorrhea Secondary to Parkinson's Disease
NeuroHealing Pharmaceuticals Inc. 19
Testing effectiveness (Phase 2)Study completedNCT00296946
What this trial is testing

Ipratropium Spray for Drooling Saliva in Parkinson's Disease

Who this might be right for
Parkinson's Disease
University Health Network, Toronto 20